Title: New therapeutic developments in renal cell cancer
Authors: Prenen, Hans ×
Gil, Thierry
Awada, Ahmad #
Issue Date: Jan-2009
Publisher: Elsevier science inc
Series Title: Critical reviews in oncology hematology vol:69 issue:1 pages:56-63
Abstract: Metastatic renal cell cancer is associated with a poor prognosis and is very resistant to conventional cytotoxic chemotherapy. Progress in the understanding of molecular biology and pathogenesis of renal cell cancer has been translated into the development of new therapeutic strategies. The recent approval Of sunitinib, sorafenib, temsirolimus and bevacizumab in combination with IFN-alpha has revolutionized the management of renal cell carcinoma.
ISSN: 1040-8428
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
Clinical Digestive Oncology (+)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science